Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Ranging Study of Tolperisone in Acute Muscle Spasm of the Back

NCT03802565 is registered in ClinicalTrials.gov with Neurana Pharmaceuticals, Inc. as lead sponsor.

NCT NCT03802565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03802565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Ranging Study of Tolperisone in Acute Muscle Spasm of the Back
Lead sponsor
Neurana Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2019
Completion date
July 12, 2019
Enrollment
415 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, back pain, back spasm upper back, back strain, low back pain, muscle cramp, muscle spasm